Needles Market Size, Share, Growth Factors, Competitive Landscape, with Regional Forecast to 2035
The prevalence of chronic conditions, including diabetes, autoimmune diseases, heart diseases, and cancer, has escalated significantly over the years. These conditions are now recognized globally as major contributors to mortality and disability.
For centuries, medical needles have been essential tools in healthcare, utilized for a wide range of procedures, including drug delivery, dental and surgical interventions, vaccine administration, and blood or specimen collection. Their precision and effectiveness in delivering targeted treatments and facilitating diagnostic processes have established them as a cornerstone of the healthcare industry.
The global needles market size is projected to grow from $8.1 billion in 2025 to $14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period.
It is worth mentioning that the number of partnerships inked in this domain has increased over time at a CAGR of 40%, since 2020. Most of the deals (20) were instances of acquisitions, enabling the players to expand their business and making their products widely accessible to the customers; examples include (in reverse chronological order, inked in 2024) acquisition of Takeda Pharmaceutical by Corza Medical (July 2024), Allmed Medical Care by Alta Semper Capital (June 2024), Sunrise Medical by Platinum Equity (June 2024), Healthium Medtech by KKR (May 2024), and SAM Medical by Tri Tech Forensics (May 2024). Other prominent types of partnership models adopted by stakeholders in this domain include commercialization agreements (8) and distribution agreements (7).
In addition, players based in North America have signed the maximum number of collaborations; of which, 19 are intracontinental agreements and 9 are intercontinental agreements. Further, most of the players based in North America signed intercontinental agreements with stakeholders headquartered in Asia-Pacific and Rest of the world-based (six), followed by stakeholders headquartered in Europe (four). Examples of recent intracontinental deals signed with players based in North America include (in reverse chronological order, headquartered in Canada) Boston Scientific and Baylis Medical Technologies (February 2022), and Montméd and Roche (January 2021).
Close to 760 patents have been filed / granted focussed on needles by industry and non-industry players to protect intellectual property generated within needles domain. the majority (48%) of the patents were published in 2022, followed by patents published in 2023 (40%). This decrease in the number of patents published in 2023 is indicative of the growing preference for alternative non-invasive routes of drug delivery, such as oral, topical and nasal routes. Additionally, around 12% of the patents in this domain have been published post-2023.
In addition to this, majority (48%) of the limited patents were published in 2022, followed by those published in 2023 (44%). This is an indicative of static patent activity for needles, owing to the stringent regulatory requirements and quality standards that can significantly complicate the development and approval processes for new needles. However, the continuous expansion of needles market is anticipated to drive patent filings as companies strive to differentiate their product portfolio to meet healthcare needs.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Needles Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
Read More :-
https://www.rootsanalysis.com/reports/needles-market.html
Needles Market Size, Share, Growth Factors, Competitive Landscape, with Regional Forecast to 2035
The prevalence of chronic conditions, including diabetes, autoimmune diseases, heart diseases, and cancer, has escalated significantly over the years. These conditions are now recognized globally as major contributors to mortality and disability.
For centuries, medical needles have been essential tools in healthcare, utilized for a wide range of procedures, including drug delivery, dental and surgical interventions, vaccine administration, and blood or specimen collection. Their precision and effectiveness in delivering targeted treatments and facilitating diagnostic processes have established them as a cornerstone of the healthcare industry.
The global needles market size is projected to grow from $8.1 billion in 2025 to $14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period.
It is worth mentioning that the number of partnerships inked in this domain has increased over time at a CAGR of 40%, since 2020. Most of the deals (20) were instances of acquisitions, enabling the players to expand their business and making their products widely accessible to the customers; examples include (in reverse chronological order, inked in 2024) acquisition of Takeda Pharmaceutical by Corza Medical (July 2024), Allmed Medical Care by Alta Semper Capital (June 2024), Sunrise Medical by Platinum Equity (June 2024), Healthium Medtech by KKR (May 2024), and SAM Medical by Tri Tech Forensics (May 2024). Other prominent types of partnership models adopted by stakeholders in this domain include commercialization agreements (8) and distribution agreements (7).
In addition, players based in North America have signed the maximum number of collaborations; of which, 19 are intracontinental agreements and 9 are intercontinental agreements. Further, most of the players based in North America signed intercontinental agreements with stakeholders headquartered in Asia-Pacific and Rest of the world-based (six), followed by stakeholders headquartered in Europe (four). Examples of recent intracontinental deals signed with players based in North America include (in reverse chronological order, headquartered in Canada) Boston Scientific and Baylis Medical Technologies (February 2022), and Montméd and Roche (January 2021).
Close to 760 patents have been filed / granted focussed on needles by industry and non-industry players to protect intellectual property generated within needles domain. the majority (48%) of the patents were published in 2022, followed by patents published in 2023 (40%). This decrease in the number of patents published in 2023 is indicative of the growing preference for alternative non-invasive routes of drug delivery, such as oral, topical and nasal routes. Additionally, around 12% of the patents in this domain have been published post-2023.
In addition to this, majority (48%) of the limited patents were published in 2022, followed by those published in 2023 (44%). This is an indicative of static patent activity for needles, owing to the stringent regulatory requirements and quality standards that can significantly complicate the development and approval processes for new needles. However, the continuous expansion of needles market is anticipated to drive patent filings as companies strive to differentiate their product portfolio to meet healthcare needs.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Needles Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
Read More :- https://www.rootsanalysis.com/reports/needles-market.html
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek